Use of gabapentin in the treatment of childhood reflex sympathetic dystrophy

Derek S. Wheeler, Keith K. Vaux, David A. Tam*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Abstract

Reflex sympathetic dystrophy, a painful syndrome involving an extremity after trauma or injury, is increasingly reported in the pediatric population. Although no clear pathophysiologic mechanism for this disorder has been identified, the role of central serotonin activity seems important. Gabapentin, a new antiepileptic medication, has been demonstrated to be effective in adults with reflex sympathetic dystrophy. The first reported case of a child with a diagnosis of reflex sympathetic dystrophy who was treated successfully with gabapentin is presented. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)220-221
Number of pages2
JournalPediatric neurology
Volume22
Issue number3
DOIs
StatePublished - Mar 2000
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Developmental Neuroscience
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Use of gabapentin in the treatment of childhood reflex sympathetic dystrophy'. Together they form a unique fingerprint.

Cite this